JaimeGerardoDevilleMD
Pediatric Infectious Disease • Los Angeles, CAHIV/AIDS Pediatrics, Pediatric Infections Associated with Transplant/Immunocompromised States
Professor, Pediatrics, UCLA School of Medicine
Dr. Deville is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10833 Le Conte Ave
# 12-441
Los Angeles, CA 90095Phone+1 310-206-3952Fax+1 310-206-0209
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterFellowship, Pediatric Infectious Diseases, 1993 - 1996
SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 1988 - 1992
Cayetano Heredia UniversityClass of 1985
Certifications & Licensure
CA State Medical License 1992 - 2026
NC State Medical License 1987 - 1999
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents Start of enrollment: 2010 Oct 08
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Start of enrollment: 2011 Nov 01
- Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT) Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07-523LS in Newborn Infants Exposed to HIV-1.Coleen K Cunningham, Elizabeth J McFarland, Petronella Muresan, Edmund V Capparelli, Charlotte Perlowski
Journal of the Pediatric Infectious Diseases Society. 2025-02-06 - Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay.Ishminder Kaur, Bennett Shaw, Ashrit Multani, Christine Pham, Sanchi Malhotra
Infection Control and Hospital Epidemiology. 2025-01-30 - 1 citationsSafety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial.Heidi Segers, Jaime G Deville, William J Muller, Angela Manzanares, Amit Desai
Antimicrobial Agents and Chemotherapy. 2024-12-05
Press Mentions
Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)December 9th, 2024- Should My Teen Get a COVID-19 Booster? Experts DiscussJanuary 6th, 2022
Miller Children’s Hospital Celebrates 20 Years of Zero Mother-Baby HIV TransmissionsNovember 23rd, 2015
Grant Support
- A Phase I/II, Multicenter, Open-Label, Noncomparative AIDS Clincal TrialsNational Center For Research Resources2010
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
